 "Though cost per ticket is likely to go up by ~150, the changing dynamics of the content ecosystem is believed to have driven the multiplex player towards taking the leap")
Shares of multiplex and diagnostic companies were abuzz on Monday, albeit for opposite reasons, as India saw a surprise spike in Covid-19 cases. India reported 4,518 cases on the day, with Maharashtra reporting 1,494 fresh cases, the highest since February 19.
With precautionary measures like mandatory masks in public being reinforced, shares of Dr Lal Path Labs, and Thyrocare gained up to 5.6 per cent, while those of Inox Leisure and PVR dropped up to 5 per cent. In comparison, the benchmark S&P BSE Sensex ended 0.17 per cent down.
The recent uptick in cases and expectations of more precautionary
